APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acetylglucosamine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acetylglucosamine Market Outlook and Growth Opportunities 2026

5 March 2026201 pages

Choose your research edition.

Industry ResearchAcetylglucosamine Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Acetylglucosamine Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Acetylglucosamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acetylglucosamine Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Acetylglucosamine Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Acetylglucosamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acetylglucosamine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acetylglucosamine market include YSK, Fengrun Biotech, Golden-shell, Aoxin-group, Rixing Biotech, Bio-gen Extracts, AdvoCare, Amicogen and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Acetylglucosamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acetylglucosamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acetylglucosamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acetylglucosamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Acetylglucosamine Segment by Company

YSK

Fengrun Biotech

Golden-shell

Aoxin-group

Rixing Biotech

Bio-gen Extracts

AdvoCare

Amicogen

Merck KGaA

Carl Roth

Kaneka

Ethical Naturals

NOW Foods

Beloor Bayir

Vitaco Health

Pure Encapsulations

Kraeber & Co

Source Naturals

NutriCology

Acetylglucosamine Segment by Type

Extraction of the Shell

Microbial Fermentation

Acetylglucosamine Segment by Application

Cosmetics

Health Care Products

Drugs

Others

Acetylglucosamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Acetylglucosamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Acetylglucosamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acetylglucosamine significant trends, drivers, influence factors in global and regions.

6. To analyze Acetylglucosamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetylglucosamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acetylglucosamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetylglucosamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Acetylglucosamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acetylglucosamine industry.

Chapter 3: Detailed analysis of Acetylglucosamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Acetylglucosamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Acetylglucosamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acetylglucosamine Industry Trends Table 2. Acetylglucosamine Industry Drivers Table 3. Acetylglucosamine Industry Opportunities and Challenges Table 4. Acetylglucosamine Industry Restraints Table 5. Global Acetylglucosamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acetylglucosamine Revenue Share by Company (2021-2026) Table 7. Global Acetylglucosamine Sales Volume by Company (t) & (2021-2026) Table 8. Global Acetylglucosamine Sales Volume Share by Company (2021-2026) Table 9. Global Acetylglucosamine Average Price (USD/t) of Company (2021-2026) Table 10. Global Acetylglucosamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Acetylglucosamine Key Company Manufacturing Base & Headquarters Table 12. Global Acetylglucosamine Company, Product Type & Application Table 13. Global Acetylglucosamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Acetylglucosamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Extraction of the Shell Table 18. Significant Companies of Microbial Fermentation Table 19. Global Acetylglucosamine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Acetylglucosamine Sales Volume by Type (2021-2026) & (t) Table 21. Global Acetylglucosamine Sales Volume by Type (2027-2032) & (t) Table 22. Global Acetylglucosamine Sales Volume Share by Type (2021-2026) Table 23. Global Acetylglucosamine Sales Volume Share by Type (2027-2032) Table 24. Global Acetylglucosamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Acetylglucosamine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Acetylglucosamine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Acetylglucosamine Sales Value Share by Type (2021-2026) Table 28. Global Acetylglucosamine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cosmetics Table 30. Significant Companies of Health Care Products Table 31. Significant Companies of Drugs Table 32. Significant Companies of Others Table 33. Global Acetylglucosamine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Acetylglucosamine Sales Volume by Application (2021-2026) & (t) Table 35. Global Acetylglucosamine Sales Volume by Application (2027-2032) & (t) Table 36. Global Acetylglucosamine Sales Volume Share by Application (2021-2026) Table 37. Global Acetylglucosamine Sales Volume Share by Application (2027-2032) Table 38. Global Acetylglucosamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Acetylglucosamine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Acetylglucosamine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Acetylglucosamine Sales Value Share by Application (2021-2026) Table 42. Global Acetylglucosamine Sales Value Share by Application (2027-2032) Table 43. Global Acetylglucosamine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Acetylglucosamine Sales by Region (2021-2026) & (t) Table 45. Global Acetylglucosamine Sales Market Share by Region (2021-2026) Table 46. Global Acetylglucosamine Sales by Region (2027-2032) & (t) Table 47. Global Acetylglucosamine Sales Market Share by Region (2027-2032) Table 48. Global Acetylglucosamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Acetylglucosamine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Acetylglucosamine Sales Value Share by Region (2021-2026) Table 51. Global Acetylglucosamine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Acetylglucosamine Sales Value Share by Region (2027-2032) Table 53. Global Acetylglucosamine Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Acetylglucosamine Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Acetylglucosamine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Acetylglucosamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Acetylglucosamine Sales by Country (2021-2026) & (t) Table 58. Global Acetylglucosamine Sales Market Share by Country (2021-2026) Table 59. Global Acetylglucosamine Sales by Country (2027-2032) & (t) Table 60. Global Acetylglucosamine Sales Market Share by Country (2027-2032) Table 61. Global Acetylglucosamine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Acetylglucosamine Sales Value Market Share by Country (2021-2026) Table 63. Global Acetylglucosamine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Acetylglucosamine Sales Value Market Share by Country (2027-2032) Table 65. YSK Company Information Table 66. YSK Business Overview Table 67. YSK Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. YSK Acetylglucosamine Product Portfolio Table 69. YSK Recent Development Table 70. Fengrun Biotech Company Information Table 71. Fengrun Biotech Business Overview Table 72. Fengrun Biotech Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Fengrun Biotech Acetylglucosamine Product Portfolio Table 74. Fengrun Biotech Recent Development Table 75. Golden-shell Company Information Table 76. Golden-shell Business Overview Table 77. Golden-shell Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Golden-shell Acetylglucosamine Product Portfolio Table 79. Golden-shell Recent Development Table 80. Aoxin-group Company Information Table 81. Aoxin-group Business Overview Table 82. Aoxin-group Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. Aoxin-group Acetylglucosamine Product Portfolio Table 84. Aoxin-group Recent Development Table 85. Rixing Biotech Company Information Table 86. Rixing Biotech Business Overview Table 87. Rixing Biotech Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Rixing Biotech Acetylglucosamine Product Portfolio Table 89. Rixing Biotech Recent Development Table 90. Bio-gen Extracts Company Information Table 91. Bio-gen Extracts Business Overview Table 92. Bio-gen Extracts Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Bio-gen Extracts Acetylglucosamine Product Portfolio Table 94. Bio-gen Extracts Recent Development Table 95. AdvoCare Company Information Table 96. AdvoCare Business Overview Table 97. AdvoCare Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. AdvoCare Acetylglucosamine Product Portfolio Table 99. AdvoCare Recent Development Table 100. Amicogen Company Information Table 101. Amicogen Business Overview Table 102. Amicogen Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. Amicogen Acetylglucosamine Product Portfolio Table 104. Amicogen Recent Development Table 105. Merck KGaA Company Information Table 106. Merck KGaA Business Overview Table 107. Merck KGaA Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. Merck KGaA Acetylglucosamine Product Portfolio Table 109. Merck KGaA Recent Development Table 110. Carl Roth Company Information Table 111. Carl Roth Business Overview Table 112. Carl Roth Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Carl Roth Acetylglucosamine Product Portfolio Table 114. Carl Roth Recent Development Table 115. Kaneka Company Information Table 116. Kaneka Business Overview Table 117. Kaneka Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 118. Kaneka Acetylglucosamine Product Portfolio Table 119. Kaneka Recent Development Table 120. Ethical Naturals Company Information Table 121. Ethical Naturals Business Overview Table 122. Ethical Naturals Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 123. Ethical Naturals Acetylglucosamine Product Portfolio Table 124. Ethical Naturals Recent Development Table 125. NOW Foods Company Information Table 126. NOW Foods Business Overview Table 127. NOW Foods Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 128. NOW Foods Acetylglucosamine Product Portfolio Table 129. NOW Foods Recent Development Table 130. Beloor Bayir Company Information Table 131. Beloor Bayir Business Overview Table 132. Beloor Bayir Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 133. Beloor Bayir Acetylglucosamine Product Portfolio Table 134. Beloor Bayir Recent Development Table 135. Vitaco Health Company Information Table 136. Vitaco Health Business Overview Table 137. Vitaco Health Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 138. Vitaco Health Acetylglucosamine Product Portfolio Table 139. Vitaco Health Recent Development Table 140. Pure Encapsulations Company Information Table 141. Pure Encapsulations Business Overview Table 142. Pure Encapsulations Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 143. Pure Encapsulations Acetylglucosamine Product Portfolio Table 144. Pure Encapsulations Recent Development Table 145. Kraeber & Co Company Information Table 146. Kraeber & Co Business Overview Table 147. Kraeber & Co Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 148. Kraeber & Co Acetylglucosamine Product Portfolio Table 149. Kraeber & Co Recent Development Table 150. Source Naturals Company Information Table 151. Source Naturals Business Overview Table 152. Source Naturals Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 153. Source Naturals Acetylglucosamine Product Portfolio Table 154. Source Naturals Recent Development Table 155. NutriCology Company Information Table 156. NutriCology Business Overview Table 157. NutriCology Acetylglucosamine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 158. NutriCology Acetylglucosamine Product Portfolio Table 159. NutriCology Recent Development Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Acetylglucosamine Distributors List Table 163. Acetylglucosamine Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Acetylglucosamine Product Image Figure 2. Global Acetylglucosamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acetylglucosamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Acetylglucosamine Sales (2021-2032) & (t) Figure 5. Global Acetylglucosamine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Acetylglucosamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Extraction of the Shell Image Figure 10. Microbial Fermentation Image Figure 11. Global Acetylglucosamine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Acetylglucosamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Acetylglucosamine Sales Volume Share by Type (2021-2032) Figure 14. Global Acetylglucosamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Acetylglucosamine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Acetylglucosamine Sales Value Share by Type (2021-2032) Figure 17. Cosmetics Image Figure 18. Health Care Products Image Figure 19. Drugs Image Figure 20. Others Image Figure 21. Global Acetylglucosamine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Acetylglucosamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Acetylglucosamine Sales Volume Share by Application (2021-2032) Figure 24. Global Acetylglucosamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Acetylglucosamine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Acetylglucosamine Sales Value Share by Application (2021-2032) Figure 27. Global Acetylglucosamine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Acetylglucosamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Acetylglucosamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Acetylglucosamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Acetylglucosamine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Acetylglucosamine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Acetylglucosamine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Acetylglucosamine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Acetylglucosamine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Acetylglucosamine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Acetylglucosamine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Acetylglucosamine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Acetylglucosamine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Acetylglucosamine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Acetylglucosamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Acetylglucosamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Acetylglucosamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Acetylglucosamine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Acetylglucosamine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Extraction of the Shell
  • Microbial Fermentation
Applications
  • Cosmetics
  • Health Care Products
  • Drugs
  • Others
Companies covered
  • YSK
  • Fengrun Biotech
  • Golden-shell
  • Aoxin-group
  • Rixing Biotech
  • Bio-gen Extracts
  • AdvoCare
  • Amicogen
  • Merck KGaA
  • Carl Roth
  • Kaneka
  • Ethical Naturals
  • NOW Foods
  • Beloor Bayir
  • Vitaco Health
  • Pure Encapsulations
  • Kraeber & Co
  • Source Naturals
  • NutriCology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acetylglucosamine Sales Value (2021-2032)
  4. 1.2.2 Global Acetylglucosamine Sales Volume (2021-2032)
  5. 1.2.3 Global Acetylglucosamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Acetylglucosamine Market Dynamics
  1. 2.1 Acetylglucosamine Industry Trends
  2. 2.2 Acetylglucosamine Industry Drivers
  3. 2.3 Acetylglucosamine Industry Opportunities and Challenges
  4. 2.4 Acetylglucosamine Industry Restraints
3 Acetylglucosamine Market by Company
  1. 3.1 Global Acetylglucosamine Company Revenue Ranking in 2025
  2. 3.2 Global Acetylglucosamine Revenue by Company (2021-2026)
  3. 3.3 Global Acetylglucosamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Acetylglucosamine Average Price by Company (2021-2026)
  5. 3.5 Global Acetylglucosamine Company Ranking (2024-2026)
  6. 3.6 Global Acetylglucosamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Acetylglucosamine Company Product Type and Application
  8. 3.8 Global Acetylglucosamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Acetylglucosamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Acetylglucosamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Acetylglucosamine Market by Type
  1. 4.1 Acetylglucosamine Type Introduction
  2. 4.1.1 Extraction of the Shell
  3. 4.1.2 Microbial Fermentation
  4. 4.2 Global Acetylglucosamine Sales Volume by Type
  5. 4.2.1 Global Acetylglucosamine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Acetylglucosamine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Acetylglucosamine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Acetylglucosamine Sales Value by Type
  9. 4.3.1 Global Acetylglucosamine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Acetylglucosamine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Acetylglucosamine Sales Value Share by Type (2021-2032)
5 Acetylglucosamine Market by Application
  1. 5.1 Acetylglucosamine Application Introduction
  2. 5.1.1 Cosmetics
  3. 5.1.2 Health Care Products
  4. 5.1.3 Drugs
  5. 5.1.4 Others
  6. 5.2 Global Acetylglucosamine Sales Volume by Application
  7. 5.2.1 Global Acetylglucosamine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Acetylglucosamine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Acetylglucosamine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Acetylglucosamine Sales Value by Application
  11. 5.3.1 Global Acetylglucosamine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Acetylglucosamine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Acetylglucosamine Sales Value Share by Application (2021-2032)
6 Acetylglucosamine Regional Sales and Value Analysis
  1. 6.1 Global Acetylglucosamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acetylglucosamine Sales by Region (2021-2032)
  3. 6.2.1 Global Acetylglucosamine Sales by Region: 2021-2026
  4. 6.2.2 Global Acetylglucosamine Sales by Region (2027-2032)
  5. 6.3 Global Acetylglucosamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Acetylglucosamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Acetylglucosamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Acetylglucosamine Sales Value by Region (2027-2032)
  9. 6.5 Global Acetylglucosamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Acetylglucosamine Sales Value (2021-2032)
  12. 6.6.2 North America Acetylglucosamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Acetylglucosamine Sales Value (2021-2032)
  15. 6.7.2 Europe Acetylglucosamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Acetylglucosamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Acetylglucosamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Acetylglucosamine Sales Value (2021-2032)
  21. 6.9.2 South America Acetylglucosamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Acetylglucosamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Acetylglucosamine Sales Value Share by Country, 2025 VS 2032
7 Acetylglucosamine Country-level Sales and Value Analysis
  1. 7.1 Global Acetylglucosamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acetylglucosamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Acetylglucosamine Sales by Country (2021-2032)
  4. 7.3.1 Global Acetylglucosamine Sales by Country (2021-2026)
  5. 7.3.2 Global Acetylglucosamine Sales by Country (2027-2032)
  6. 7.4 Global Acetylglucosamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Acetylglucosamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Acetylglucosamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Acetylglucosamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Acetylglucosamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Acetylglucosamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Acetylglucosamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Acetylglucosamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Acetylglucosamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Acetylglucosamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Acetylglucosamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Acetylglucosamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Acetylglucosamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Acetylglucosamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Acetylglucosamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Acetylglucosamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Acetylglucosamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Acetylglucosamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Acetylglucosamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Acetylglucosamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Acetylglucosamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Acetylglucosamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Acetylglucosamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Acetylglucosamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Acetylglucosamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Acetylglucosamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Acetylglucosamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Acetylglucosamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Acetylglucosamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Acetylglucosamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Acetylglucosamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Acetylglucosamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Acetylglucosamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 YSK
  2. 8.1.1 YSK Company Information
  3. 8.1.2 YSK Business Overview
  4. 8.1.3 YSK Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 YSK Acetylglucosamine Product Portfolio
  6. 8.1.5 YSK Recent Developments
  7. 8.2 Fengrun Biotech
  8. 8.2.1 Fengrun Biotech Company Information
  9. 8.2.2 Fengrun Biotech Business Overview
  10. 8.2.3 Fengrun Biotech Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fengrun Biotech Acetylglucosamine Product Portfolio
  12. 8.2.5 Fengrun Biotech Recent Developments
  13. 8.3 Golden-shell
  14. 8.3.1 Golden-shell Company Information
  15. 8.3.2 Golden-shell Business Overview
  16. 8.3.3 Golden-shell Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Golden-shell Acetylglucosamine Product Portfolio
  18. 8.3.5 Golden-shell Recent Developments
  19. 8.4 Aoxin-group
  20. 8.4.1 Aoxin-group Company Information
  21. 8.4.2 Aoxin-group Business Overview
  22. 8.4.3 Aoxin-group Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Aoxin-group Acetylglucosamine Product Portfolio
  24. 8.4.5 Aoxin-group Recent Developments
  25. 8.5 Rixing Biotech
  26. 8.5.1 Rixing Biotech Company Information
  27. 8.5.2 Rixing Biotech Business Overview
  28. 8.5.3 Rixing Biotech Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Rixing Biotech Acetylglucosamine Product Portfolio
  30. 8.5.5 Rixing Biotech Recent Developments
  31. 8.6 Bio-gen Extracts
  32. 8.6.1 Bio-gen Extracts Company Information
  33. 8.6.2 Bio-gen Extracts Business Overview
  34. 8.6.3 Bio-gen Extracts Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bio-gen Extracts Acetylglucosamine Product Portfolio
  36. 8.6.5 Bio-gen Extracts Recent Developments
  37. 8.7 AdvoCare
  38. 8.7.1 AdvoCare Company Information
  39. 8.7.2 AdvoCare Business Overview
  40. 8.7.3 AdvoCare Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AdvoCare Acetylglucosamine Product Portfolio
  42. 8.7.5 AdvoCare Recent Developments
  43. 8.8 Amicogen
  44. 8.8.1 Amicogen Company Information
  45. 8.8.2 Amicogen Business Overview
  46. 8.8.3 Amicogen Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Amicogen Acetylglucosamine Product Portfolio
  48. 8.8.5 Amicogen Recent Developments
  49. 8.9 Merck KGaA
  50. 8.9.1 Merck KGaA Company Information
  51. 8.9.2 Merck KGaA Business Overview
  52. 8.9.3 Merck KGaA Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck KGaA Acetylglucosamine Product Portfolio
  54. 8.9.5 Merck KGaA Recent Developments
  55. 8.10 Carl Roth
  56. 8.10.1 Carl Roth Company Information
  57. 8.10.2 Carl Roth Business Overview
  58. 8.10.3 Carl Roth Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Carl Roth Acetylglucosamine Product Portfolio
  60. 8.10.5 Carl Roth Recent Developments
  61. 8.11 Kaneka
  62. 8.11.1 Kaneka Company Information
  63. 8.11.2 Kaneka Business Overview
  64. 8.11.3 Kaneka Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kaneka Acetylglucosamine Product Portfolio
  66. 8.11.5 Kaneka Recent Developments
  67. 8.12 Ethical Naturals
  68. 8.12.1 Ethical Naturals Company Information
  69. 8.12.2 Ethical Naturals Business Overview
  70. 8.12.3 Ethical Naturals Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ethical Naturals Acetylglucosamine Product Portfolio
  72. 8.12.5 Ethical Naturals Recent Developments
  73. 8.13 NOW Foods
  74. 8.13.1 NOW Foods Company Information
  75. 8.13.2 NOW Foods Business Overview
  76. 8.13.3 NOW Foods Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 NOW Foods Acetylglucosamine Product Portfolio
  78. 8.13.5 NOW Foods Recent Developments
  79. 8.14 Beloor Bayir
  80. 8.14.1 Beloor Bayir Company Information
  81. 8.14.2 Beloor Bayir Business Overview
  82. 8.14.3 Beloor Bayir Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Beloor Bayir Acetylglucosamine Product Portfolio
  84. 8.14.5 Beloor Bayir Recent Developments
  85. 8.15 Vitaco Health
  86. 8.15.1 Vitaco Health Company Information
  87. 8.15.2 Vitaco Health Business Overview
  88. 8.15.3 Vitaco Health Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Vitaco Health Acetylglucosamine Product Portfolio
  90. 8.15.5 Vitaco Health Recent Developments
  91. 8.16 Pure Encapsulations
  92. 8.16.1 Pure Encapsulations Company Information
  93. 8.16.2 Pure Encapsulations Business Overview
  94. 8.16.3 Pure Encapsulations Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Pure Encapsulations Acetylglucosamine Product Portfolio
  96. 8.16.5 Pure Encapsulations Recent Developments
  97. 8.17 Kraeber & Co
  98. 8.17.1 Kraeber & Co Company Information
  99. 8.17.2 Kraeber & Co Business Overview
  100. 8.17.3 Kraeber & Co Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Kraeber & Co Acetylglucosamine Product Portfolio
  102. 8.17.5 Kraeber & Co Recent Developments
  103. 8.18 Source Naturals
  104. 8.18.1 Source Naturals Company Information
  105. 8.18.2 Source Naturals Business Overview
  106. 8.18.3 Source Naturals Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Source Naturals Acetylglucosamine Product Portfolio
  108. 8.18.5 Source Naturals Recent Developments
  109. 8.19 NutriCology
  110. 8.19.1 NutriCology Company Information
  111. 8.19.2 NutriCology Business Overview
  112. 8.19.3 NutriCology Acetylglucosamine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 NutriCology Acetylglucosamine Product Portfolio
  114. 8.19.5 NutriCology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Acetylglucosamine Value Chain Analysis
  2. 9.1.1 Acetylglucosamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Acetylglucosamine Sales Mode & Process
  6. 9.2 Acetylglucosamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Acetylglucosamine Distributors
  9. 9.2.3 Acetylglucosamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst